Polycystic ovarian syndrome (PCOS) is the most common endocrine–metabolic disorder
affecting a vast population worldwide; it is linked with anovulation, mitochondrial …

Polycystic ovary syndrome (PCOS) is increasingly recognized as a complex metabolic
disorder that manifests in genetically susceptible women following a range of negative …

Background Accumulating evidence suggests a strong association between polycystic ovary
syndrome (PCOS) and ovarian cancer (OC), but the potential molecular mechanism remains …

Circadian rhythms (CRs) are fundamental biological processes that significantly impact
human well-being. Disruption of these rhythms can trigger insufficient neurocognitive …

Ovarian cancer is a frequent malignancy that affects a large percentage of women.
Endometriosis is a chronic condition, where there is a production of benign lesions were …

Polycystic ovary syndrome (PCOS) is increasingly being characterized as an evolutionary
mismatch disorder that presents with a complex mixture of metabolic and endocrine …

Polycystic ovary syndrome (PCOS) is a multi-causal condition. Among the genetic causes,
variations in the mitochondrial DNA (mtDNA) are increasingly recognised as causative …

The druggable proteome refers to proteins that can bind to small molecules with appropriate
chemical affinity, inducing a favorable clinical response. Predicting druggable proteins …

Epigenetic modifications, characterized by changes in gene expression without altering the
DNA sequence, play a crucial role in the development and progression of cancer by …

Pharmacological drugs targeting specific pathways involved in various diseases have seen
recent advancement with newer and more efficient emerging drug targets, but these drugs …